MOLECULE HOLDINGS Working Capital to Net Assets Ratio
MOLECULE HOLDINGS working capital to net assets ratio. MOLECULE HOLDINGS (ERV2) has a Working Capital to Net Assets ratio of 168.8% as of October 2022. Working capital of €-6.24 Million (current assets of €1.28 Million minus current liabilities of €7.52 Million) is measured against net assets of €-3.69 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check MOLECULE HOLDINGS tangible equity quality to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of MOLECULE HOLDINGS (2021–2022)
Working capital to net assets ratio of MOLECULE HOLDINGS from 2021 to 2022. This chart shows how MOLECULE HOLDINGS's Working Capital to Net Assets ratio has evolved across 2 annual periods from 2021 to 2022. As of October 2022, the ratio stands at 168.8%, reflecting working capital of €-6.24 Million against net assets of €-3.69 Million EUR. See ERV2 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
MOLECULE HOLDINGS Working Capital to Net Assets Ratio by Year (2021–2022)
MOLECULE HOLDINGS working capital to net assets ratio by year from 2021 to 2022. The table below presents the year-by-year Working Capital to Net Assets ratio for MOLECULE HOLDINGS from 2021 to 2022, covering 2 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see ERV2 current and non-current assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 168.8% | €-6.24 Million | €-3.69 Million | €1.28 Million | €7.52 Million | ▲ +426.9 pp |
| 2021 | -258.1% | €-1.65 Million | €638.39K | €2.71 Million | €4.35 Million | — |